BeiGene Ltd. (BGNE) NASDAQ
$175 (4.36) (-2.43%)
Market Cap: $16.68B
As of 12/08/23 04:00 PM EST. Market closed.
BeiGene Ltd. (BGNE)
NASDAQ
$175
(4.36) (-2.43%)
Market Cap: $16.68B
As of 12/08/23 04:00 PM EST. Market closed.
Add to Portfolio
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and ... read more
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Oyler
Full Time Employees
5,300
URL
Address
No. 30 Science Park Road, Zhong-Guan-Cun Life Science Park, Beijing, Changping District, BEIJING.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Oyler
Full Time Employees
5,300
URL
Address
No. 30 Science Park Road, Zhong-Guan-Cun Life Science Park, Beijing, Changping District, BEIJING.
PRICE CHART FOR BEIGENE LTD
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$177.81
Previous Close
$179.36
Days Range
$174 - $178.38
52 week range
$156.56 - $280.62
Volume
238,529
Avg. Volume (30 days)
198,319
Market Cap
$16.68B
Dividend Yield
-
P/E
(17.47)
Shares Outstanding
95,311,581
Open
$177.81
Previous Close
$179.36
Days Range
$174 - $178.38
52 week range
$156.56 - $280.62
Volume
238,529
Avg. Volume (30 days)
198,319
Market Cap
$16.68B
Dividend Yield
-
P/E
(17.47)
Shares Outstanding
95,311,581
FINANCIAL STATEMENTS FOR BEIGENE LTD
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BEIGENE LTD
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Sale | $180.50 | 1,100,000 | 198,550,000 | 9,691,294 | Nov 14, 2023, 05:54 PM |
| Lee Chan Henry | SVP, General Counsel | Jul 31, 2023 | Sale | $216.26 | 791 | 171,059 | 0 | Aug 02, 2023, 05:10 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 03, 2023 | Sale | $179.55 | 472 | 84,747 | 0 | Jul 06, 2023, 05:02 PM |
| Wang Lai | Global Head of R&D | Jun 26, 2023 | Sale | $181.92 | 1,108 | 201,567 | 5 | Jun 27, 2023, 05:24 PM |
| Wang Julia Aijun | Chief Financial Officer | Jun 23, 2023 | Sale | $182.85 | 840 | 153,594 | 0 | Jun 27, 2023, 05:22 PM |
| Sanders Corazon (Corsee) D. | Director | Jun 23, 2023 | Sale | $182.32 | 578 | 105,381 | 478 | Jun 27, 2023, 05:21 PM |
| Wu Xiaobin | President, COO & GM China | Jun 26, 2023 | Sale | $182.37 | 1,495 | 272,636 | 0 | Jun 27, 2023, 05:20 PM |
| Wang Lai | Global Head of R&D | Jun 20, 2023 | Sale | $192.42 | 1,325 | 254,955 | 0 | Jun 20, 2023, 06:53 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 13, 2023 | Sale | $183.31 | 924,400 | 169,448,350 | 143,475,369 | Jun 15, 2023, 07:25 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 14, 2023 | Sale | $207.72 | 273,728 | 56,857,987 | 142,888,241 | Jun 15, 2023, 07:25 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 12, 2023 | Sale | $195.21 | 1,250,212 | 244,057,184 | 145,055,181 | Jun 12, 2023, 09:57 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 09, 2023 | Sale | $182.89 | 542,652 | 99,244,888 | 145,665,533 | Jun 12, 2023, 09:57 PM |
| HHLR ADVISORS, LTD. | 10% Owner | Jun 08, 2023 | Sale | $218.14 | 1,163,825 | 253,881,793 | 145,879,233 | Jun 12, 2023, 09:57 PM |
| Wang Lai | Global Head of R&D | Jun 07, 2023 | Sale | $224.74 | 462 | 103,828 | 388 | Jun 09, 2023, 05:46 PM |
| Wu Xiaobin | President, COO & GM China | Jun 07, 2023 | Sale | $224.73 | 3,291 | 739,599 | 2,760 | Jun 09, 2023, 05:44 PM |
| Wu Xiaobin | President, COO & GM China | May 08, 2023 | Sale | $253.72 | 7,000 | 1,776,037 | 0 | May 10, 2023, 04:44 PM |
| Wang Xiaodong | Director | Mar 08, 2023 | Option Exercise | $0.13 | 67,635 | 8,793 | 67,635 | Mar 10, 2023, 06:48 PM |
| Wang Xiaodong | Director | Mar 08, 2023 | Sale | $226.03 | 67,635 | 15,287,339 | 64,202 | Mar 10, 2023, 06:48 PM |
| Wang Xiaodong | Director | Jan 12, 2023 | Sale | $260.52 | 5,000 | 1,302,585 | 901 | Jan 17, 2023, 05:13 PM |
| OYLER JOHN | Chief Executive Officer | Jan 10, 2023 | Sale | $248.51 | 13,594 | 3,378,292 | 5,918 | Jan 12, 2023, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Jan 10, 2023 | Sale | $248.52 | 6,797 | 1,689,157 | 5,918 | Jan 12, 2023, 04:52 PM |
| Wang Xiaodong | Director | Jan 10, 2023 | Sale | $250.09 | 1,600 | 400,152 | 0 | Jan 11, 2023, 04:50 PM |
| Wang Xiaodong | Director | Jan 09, 2023 | Sale | $250.00 | 900 | 225,000 | 0 | Jan 11, 2023, 04:50 PM |
| Wang Xiaodong | Director | Jan 11, 2023 | Sale | $252.66 | 2,500 | 631,647 | 2,300 | Jan 11, 2023, 04:50 PM |
| OYLER JOHN | Chief Executive Officer | Dec 27, 2022 | Sale | $224.29 | 2,239 | 502,193 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 27, 2022 | Sale | $224.29 | 1,120 | 251,209 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 29, 2022 | Sale | $224.46 | 3,434 | 770,798 | 92 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 29, 2022 | Sale | $224.46 | 1,716 | 385,174 | 91 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 28, 2022 | Sale | $224.73 | 733 | 164,724 | 0 | Dec 29, 2022, 06:24 PM |
| OYLER JOHN | Chief Executive Officer | Dec 28, 2022 | Sale | $224.73 | 367 | 82,474 | 0 | Dec 29, 2022, 06:24 PM |
| Wang Xiaodong | Director | Dec 13, 2022 | Sale | $211.33 | 3,013 | 636,724 | 1,621 | Dec 15, 2022, 05:04 PM |
| Wang Xiaodong | Director | Nov 15, 2022 | Sale | $210.14 | 1,987 | 417,542 | 0 | Nov 17, 2022, 05:13 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2022 | Sale | $206.82 | 4,928 | 1,019,229 | 4,228 | Nov 17, 2022, 05:10 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2022 | Sale | $206.84 | 25,000 | 5,171,104 | 23,600 | Nov 17, 2022, 05:10 PM |
| OYLER JOHN | Chief Executive Officer | Sep 20, 2022 | Sale | $153.50 | 30,520 | 4,684,837 | 5,512 | Sep 22, 2022, 05:34 PM |
| OYLER JOHN | Chief Executive Officer | Sep 21, 2022 | Sale | $149.99 | 19,480 | 2,921,712 | 7,740 | Sep 22, 2022, 05:34 PM |
| Wang Xiaodong | Director | Aug 08, 2022 | Sale | $201.25 | 6,060 | 1,219,594 | 3,086 | Aug 09, 2022, 07:00 PM |
| Wang Xiaodong | Director | Aug 05, 2022 | Sale | $193.85 | 5,000 | 969,256 | 4,700 | Aug 09, 2022, 07:00 PM |
| Wang Xiaodong | Director | Aug 05, 2022 | Sale | $193.85 | 5,000 | 969,272 | 4,700 | Aug 09, 2022, 07:00 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2022 | Sale | $158.50 | 317 | 50,245 | 0 | Jul 18, 2022, 05:22 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2022 | Sale | $158.50 | 295 | 46,758 | 0 | Jul 05, 2022, 05:29 PM |
| Wang Lai | Global Head of R&D | Jun 27, 2022 | Sale | $177.32 | 458 | 81,215 | 0 | Jun 28, 2022, 05:32 PM |
| Wang Lai | Global Head of R&D | Jun 21, 2022 | Sale | $149.01 | 723 | 107,734 | 0 | Jun 22, 2022, 05:47 PM |
| Wang Lai | Global Head of R&D | Jun 17, 2022 | Sale | $139.40 | 445 | 62,034 | 723 | Jun 22, 2022, 05:47 PM |
| Wu Xiaobin | President, COO & GM China | Jun 21, 2022 | Sale | $144.36 | 1,010 | 145,804 | 0 | Jun 22, 2022, 05:45 PM |
| Wu Xiaobin | President, COO & GM China | Jun 17, 2022 | Sale | $139.60 | 578 | 80,691 | 1,010 | Jun 22, 2022, 05:45 PM |
| Wang Julia Aijun | Chief Financial Officer | Jun 17, 2022 | Sale | $136.64 | 161 | 21,999 | 0 | Jun 21, 2022, 05:09 PM |
| Wang Lai | Global Head of R&D | Jun 06, 2022 | Sale | $142.00 | 660 | 93,717 | 0 | Jun 08, 2022, 05:43 PM |
| Wu Xiaobin | President, COO & GM China | Jun 06, 2022 | Sale | $141.99 | 3,410 | 484,203 | 0 | Jun 08, 2022, 05:42 PM |
| Wang Lai | Global Head of R&D | May 17, 2022 | Option Exercise | $3.26 | 1,233,947 | 4,025,737 | 1,408,498 | May 19, 2022, 04:39 PM |
| Wu Xiaobin | President, COO & GM China | May 05, 2022 | Sale | $164.35 | 6,725 | 1,105,275 | 5,925 | May 06, 2022, 05:15 PM |
| Huang Jane | CMO, Hematology | Dec 14, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Dec 16, 2021, 05:50 PM |
| Huang Jane | CMO, Hematology | Dec 14, 2021 | Sale | $278.14 | 1,500 | 417,211 | 1,200 | Dec 16, 2021, 05:50 PM |
| Huang Jane | CMO, Hematology | Dec 01, 2021 | Sale | $359.86 | 1,049 | 377,493 | 519 | Dec 02, 2021, 06:21 PM |
| Huang Jane | CMO, Hematology | Nov 17, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Nov 19, 2021, 06:18 PM |
| Huang Jane | CMO, Hematology | Nov 17, 2021 | Sale | $381.34 | 1,500 | 572,003 | 1,300 | Nov 19, 2021, 06:18 PM |
| Wang Xiaodong | Director | Nov 08, 2021 | Sale | $350.04 | 4,500 | 1,575,202 | 4,100 | Nov 10, 2021, 05:30 PM |
| Wang Xiaodong | Director | Nov 08, 2021 | Sale | $349.81 | 4,500 | 1,574,148 | 4,200 | Nov 10, 2021, 05:25 PM |
| Wu Xiaobin | President, COO & GM China | Nov 09, 2021 | Sale | $366.34 | 2,334 | 855,038 | 2,034 | Nov 10, 2021, 05:14 PM |
| Wu Xiaobin | President, COO & GM China | Nov 08, 2021 | Sale | $355.81 | 7,666 | 2,727,625 | 7,366 | Nov 10, 2021, 05:14 PM |
| Huang Jane | CMO, Hematology | Oct 19, 2021 | Option Exercise | $119.96 | 1,500 | 179,940 | 1,500 | Oct 21, 2021, 05:37 PM |
| Huang Jane | CMO, Hematology | Oct 19, 2021 | Sale | $372.78 | 1,500 | 559,163 | 1,300 | Oct 21, 2021, 05:37 PM |
| Huang Jane | CMO, Hematology | Sep 20, 2021 | Option Exercise | $119.96 | 6,000 | 719,760 | 6,000 | Sep 22, 2021, 06:15 PM |
| Huang Jane | CMO, Hematology | Sep 20, 2021 | Sale | $397.96 | 6,000 | 2,387,774 | 5,900 | Sep 22, 2021, 06:15 PM |
| OYLER JOHN | Chief Executive Officer | Sep 15, 2021 | Sale | $71.36 | 216,361 | 15,439,460 | 1,736,904 | Sep 16, 2021, 06:06 PM |
| OYLER JOHN | Chief Executive Officer | Sep 14, 2021 | Sale | $93.87 | 195,477 | 18,348,858 | 2,267,161 | Sep 16, 2021, 06:06 PM |
| Huang Jane | CMO, Hematology | Sep 13, 2021 | Sale | $358.14 | 12,901 | 4,620,392 | 8,682 | Sep 15, 2021, 06:16 PM |
| AMGEN INC | 10% Owner | Sep 10, 2021 | Buy | $302.06 | 165,529 | 49,999,856 | 18,943,802 | Sep 13, 2021, 07:27 PM |
| OYLER JOHN | Chief Executive Officer | Sep 02, 2021 | Sale | $328.21 | 24,499 | 8,040,809 | 20,099 | Sep 02, 2021, 08:40 PM |
| OYLER JOHN | Chief Executive Officer | Sep 01, 2021 | Sale | $74.56 | 153,059 | 11,411,639 | 3,567,562 | Sep 02, 2021, 08:40 PM |
| OYLER JOHN | Chief Executive Officer | Aug 31, 2021 | Sale | $110.13 | 111,081 | 12,232,867 | 3,694,720 | Sep 02, 2021, 08:40 PM |
| Huang Jane | CMO, Hematology | Sep 02, 2021 | Sale | $327.18 | 545 | 178,314 | 0 | Sep 02, 2021, 08:39 PM |
| Huang Jane | CMO, Hematology | Sep 01, 2021 | Sale | $310.53 | 542 | 168,307 | 0 | Sep 02, 2021, 08:39 PM |
| OYLER JOHN | Chief Executive Officer | Aug 04, 2021 | Sale | $150.97 | 80,847 | 12,205,592 | 4,385,979 | Aug 05, 2021, 09:03 PM |
| OYLER JOHN | Chief Executive Officer | Aug 05, 2021 | Sale | $98.47 | 44,462 | 4,378,046 | 4,217,173 | Aug 05, 2021, 09:03 PM |
| OYLER JOHN | Chief Executive Officer | Aug 03, 2021 | Sale | $182.37 | 83,359 | 15,202,040 | 4,847,790 | Aug 05, 2021, 09:01 PM |
| OYLER JOHN | Chief Executive Officer | Jul 22, 2021 | Sale | $71.82 | 69,216 | 4,971,359 | 5,434,657 | Jul 22, 2021, 06:23 PM |
| OYLER JOHN | Chief Executive Officer | Jul 21, 2021 | Sale | $184.09 | 27,160 | 4,999,824 | 5,639,665 | Jul 22, 2021, 06:21 PM |
| OYLER JOHN | Chief Executive Officer | Jul 20, 2021 | Sale | $132.26 | 43,695 | 5,779,054 | 5,849,945 | Jul 22, 2021, 06:21 PM |
| Huang Jane | CMO, Hematology | Jul 15, 2021 | Option Exercise | $146.90 | 21,000 | 3,085,002 | 21,000 | Jul 19, 2021, 04:43 PM |
| Huang Jane | CMO, Hematology | Jul 15, 2021 | Sale | $332.42 | 21,000 | 6,980,771 | 18,621 | Jul 19, 2021, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2021 | Sale | $325.23 | 300 | 97,570 | 0 | Jul 08, 2021, 07:11 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2021 | Sale | $93.80 | 67,181 | 6,301,730 | 6,085,580 | Jul 08, 2021, 07:11 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2021 | Sale | $137.54 | 66,446 | 9,139,023 | 6,343,333 | Jul 08, 2021, 07:09 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2021 | Sale | $93.69 | 57,375 | 5,375,612 | 6,722,631 | Jul 08, 2021, 07:09 PM |
| Wu Xiaobin | President, COO & GM China | Jul 06, 2021 | Sale | $325.53 | 10,180 | 3,313,928 | 9,780 | Jul 08, 2021, 06:25 PM |
| Wang Xiaodong | Director | Jul 01, 2021 | Sale | $348.15 | 4,848 | 1,687,852 | 4,548 | Jul 01, 2021, 06:01 PM |
| Wang Julia Aijun | Chief Financial Officer | Jul 01, 2021 | Sale | $349.06 | 308 | 107,512 | 0 | Jul 01, 2021, 04:58 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 30, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2021 | Sale | $352.13 | 1,500 | 528,198 | 1,200 | Jun 30, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 28, 2021 | Sale | $365.00 | 425 | 155,125 | 0 | Jun 30, 2021, 04:49 PM |
| Wang Lai | Global Head of R&D | Jun 28, 2021 | Sale | $362.48 | 455 | 164,930 | 0 | Jun 30, 2021, 04:48 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 28, 2021 | Sale | $365.00 | 446 | 162,790 | 0 | Jun 30, 2021, 04:45 PM |
| Huang Jane | CMO, Hematology | Jun 18, 2021 | Sale | $325.66 | 469 | 152,733 | 0 | Jun 21, 2021, 04:45 PM |
| Chen Timothy Yung-Cheng | Director | Jun 10, 2021 | Option Exercise | $31.59 | 2,836 | 89,589 | 2,836 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 09, 2021 | Option Exercise | $31.59 | 3,164 | 99,951 | 3,164 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 10, 2021 | Sale | $352.03 | 2,836 | 998,348 | 2,152 | Jun 11, 2021, 04:36 PM |
| Chen Timothy Yung-Cheng | Director | Jun 09, 2021 | Sale | $351.35 | 3,164 | 1,111,669 | 1,801 | Jun 11, 2021, 04:36 PM |
| Wu Xiaobin | President, COO & GM China | Jun 07, 2021 | Sale | $352.54 | 3,398 | 1,197,918 | 573 | Jun 09, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jun 07, 2021 | Sale | $351.55 | 603 | 211,986 | 0 | Jun 09, 2021, 04:45 PM |
| Wang Xiaodong | Director | May 10, 2021 | Option Exercise | $0.13 | 47,503 | 6,175 | 5,747,271 | May 12, 2021, 04:32 PM |
| Wang Xiaodong | Director | May 10, 2021 | Sale | $300.46 | 3,394 | 1,019,751 | 2,294 | May 12, 2021, 04:32 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | May 03, 2021, 04:35 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2021 | Sale | $354.92 | 1,500 | 532,387 | 1,400 | May 03, 2021, 04:35 PM |
| Huang Jane | CMO, Hematology | Mar 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Mar 31, 2021, 04:46 PM |
| Huang Jane | CMO, Hematology | Mar 29, 2021 | Sale | $324.00 | 1,500 | 485,993 | 1,200 | Mar 31, 2021, 04:46 PM |
| Huang Jane | CMO, Hematology | Feb 26, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Mar 02, 2021, 04:52 PM |
| Huang Jane | CMO, Hematology | Feb 26, 2021 | Sale | $320.73 | 1,500 | 481,099 | 1,400 | Mar 02, 2021, 04:52 PM |
| Huang Jane | CMO, Hematology | Jan 29, 2021 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Feb 02, 2021, 04:49 PM |
| Huang Jane | CMO, Hematology | Jan 29, 2021 | Sale | $322.99 | 1,500 | 484,492 | 1,200 | Feb 02, 2021, 04:49 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 14, 2021 | Option Exercise | $6.50 | 1,400 | 9,100 | 1,400 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 15, 2021 | Option Exercise | $6.50 | 12,600 | 81,900 | 12,600 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 14, 2021 | Sale | $344.47 | 1,400 | 482,256 | 300 | Jan 19, 2021, 05:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jan 15, 2021 | Sale | $344.90 | 12,600 | 4,345,687 | 5,606 | Jan 19, 2021, 05:04 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 04, 2021 | Sale | $220.50 | 121,154 | 26,714,457 | 10,699,954 | Jan 06, 2021, 06:32 PM |
| Huang Jane | CMO, Hematology | Dec 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 30, 2020, 04:34 PM |
| Huang Jane | CMO, Hematology | Dec 29, 2020 | Sale | $249.13 | 1,500 | 373,690 | 1,300 | Dec 30, 2020, 04:34 PM |
| AMGEN INC | 10% Owner | Dec 18, 2020 | Option Exercise | $260.95 | 25,762 | 6,722,516 | 18,778,273 | Dec 18, 2020, 09:25 PM |
| AMGEN INC | 10% Owner | Dec 16, 2020 | Option Exercise | $248.26 | 85,573 | 21,244,439 | 18,677,887 | Dec 17, 2020, 09:18 PM |
| AMGEN INC | 10% Owner | Dec 15, 2020 | Option Exercise | $239.31 | 67,941 | 16,258,757 | 18,592,314 | Dec 17, 2020, 09:18 PM |
| AMGEN INC | 10% Owner | Dec 17, 2020 | Option Exercise | $260.54 | 74,624 | 19,442,538 | 18,752,511 | Dec 17, 2020, 09:18 PM |
| Liang Howard | CFO & Chief Strategy Officer | Dec 14, 2020 | Option Exercise | $0.87 | 1,497,200 | 1,300,000 | 1,573,715 | Dec 16, 2020, 04:43 PM |
| Liang Howard | CFO & Chief Strategy Officer | Dec 14, 2020 | Sale | $229.04 | 91,900 | 21,048,471 | 87,800 | Dec 16, 2020, 04:43 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 04, 2020 | Sale | $220.50 | 1,511,546 | 333,295,893 | 10,811,048 | Dec 04, 2020, 05:24 PM |
| Huang Jane | CMO, Hematology | Nov 30, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 02, 2020, 05:01 PM |
| Huang Jane | CMO, Hematology | Nov 30, 2020 | Sale | $267.81 | 1,500 | 401,722 | 1,396 | Dec 02, 2020, 05:01 PM |
| Huang Jane | CMO, Hematology | Oct 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Nov 02, 2020, 04:44 PM |
| Huang Jane | CMO, Hematology | Oct 29, 2020 | Sale | $300.06 | 1,500 | 450,092 | 239 | Nov 02, 2020, 04:44 PM |
| Wang Xiaodong | Director | Oct 16, 2020 | Sale | $320.00 | 5,000 | 1,600,000 | 0 | Oct 20, 2020, 04:44 PM |
| Wang Xiaodong | Director | Oct 05, 2020 | Sale | $300.00 | 5,000 | 1,500,000 | 0 | Oct 07, 2020, 04:56 PM |
| Wu Xiaobin | President & GM China | Oct 05, 2020 | Sale | $300.00 | 4,000 | 1,200,000 | 0 | Oct 07, 2020, 04:52 PM |
| Liang Howard | CFO & Chief Strategy Officer | Oct 05, 2020 | Option Exercise | $6.50 | 14,000 | 91,000 | 14,000 | Oct 07, 2020, 04:50 PM |
| Liang Howard | CFO & Chief Strategy Officer | Oct 05, 2020 | Sale | $299.60 | 14,000 | 4,194,415 | 13,183 | Oct 07, 2020, 04:50 PM |
| Huang Jane | CMO, Hematology | Sep 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Oct 01, 2020, 04:52 PM |
| Huang Jane | CMO, Hematology | Sep 29, 2020 | Sale | $280.38 | 1,500 | 420,568 | 1,300 | Oct 01, 2020, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Sep 29, 2020 | Sale | $280.82 | 23,303 | 6,544,031 | 22,853 | Sep 30, 2020, 04:53 PM |
| OYLER JOHN | Chief Executive Officer | Sep 28, 2020 | Sale | $280.07 | 31,000 | 8,682,061 | 28,767 | Sep 30, 2020, 04:53 PM |
| Wang Xiaodong | Director | Sep 25, 2020 | Sale | $280.42 | 5,000 | 1,402,117 | 620 | Sep 29, 2020, 04:59 PM |
| Wu Xiaobin | President & GM China | Sep 25, 2020 | Sale | $280.35 | 4,000 | 1,121,408 | 0 | Sep 29, 2020, 04:57 PM |
| Wang Xiaodong | Director | Sep 17, 2020 | Sale | $260.27 | 5,000 | 1,301,358 | 84 | Sep 21, 2020, 04:53 PM |
| Wu Xiaobin | President & GM China | Sep 17, 2020 | Sale | $260.33 | 4,000 | 1,041,326 | 500 | Sep 21, 2020, 04:50 PM |
| OYLER JOHN | Chief Executive Officer | Sep 16, 2020 | Sale | $254.77 | 27,275 | 6,948,803 | 16,963 | Sep 16, 2020, 05:12 PM |
| OYLER JOHN | Chief Executive Officer | Sep 15, 2020 | Sale | $254.26 | 34,214 | 8,699,382 | 32,014 | Sep 16, 2020, 05:12 PM |
| OYLER JOHN | Chief Executive Officer | Sep 14, 2020 | Sale | $250.25 | 19,739 | 4,939,776 | 19,139 | Sep 16, 2020, 05:12 PM |
| Liang Howard | CFO & Chief Strategy Officer | Sep 14, 2020 | Option Exercise | $6.50 | 14,000 | 91,000 | 14,000 | Sep 16, 2020, 05:10 PM |
| Liang Howard | CFO & Chief Strategy Officer | Sep 14, 2020 | Sale | $250.27 | 14,000 | 3,503,765 | 13,600 | Sep 16, 2020, 05:10 PM |
| Huang Jane | CMO, Hematology | Sep 03, 2020 | Sale | $233.07 | 3,128 | 729,044 | 2,128 | Sep 08, 2020, 04:44 PM |
| OYLER JOHN | Chief Executive Officer | Sep 02, 2020 | Sale | $229.22 | 27,807 | 6,374,025 | 26,607 | Sep 02, 2020, 05:44 PM |
| OYLER JOHN | Chief Executive Officer | Sep 01, 2020 | Sale | $233.79 | 20,274 | 4,739,812 | 16,329 | Sep 02, 2020, 05:44 PM |
| OYLER JOHN | Chief Executive Officer | Aug 31, 2020 | Sale | $240.86 | 12,961 | 3,121,766 | 11,861 | Sep 02, 2020, 05:44 PM |
| Huang Jane | CMO, Hematology | Aug 28, 2020 | Option Exercise | $29.49 | 3,000 | 88,470 | 3,000 | Sep 01, 2020, 04:41 PM |
| Huang Jane | CMO, Hematology | Aug 28, 2020 | Sale | $242.21 | 3,000 | 726,627 | 2,200 | Sep 01, 2020, 04:41 PM |
| AMGEN INC | 10% Owner | Aug 25, 2020 | Option Exercise | $248.49 | 59,390 | 14,757,583 | 18,524,373 | Aug 25, 2020, 05:55 PM |
| AMGEN INC | 10% Owner | Aug 24, 2020 | Option Exercise | $239.10 | 59,390 | 14,199,911 | 18,464,983 | Aug 24, 2020, 05:47 PM |
| AMGEN INC | 10% Owner | Aug 21, 2020 | Option Exercise | $230.18 | 64,176 | 14,772,031 | 18,405,593 | Aug 24, 2020, 05:47 PM |
| OYLER JOHN | Chief Executive Officer | Aug 21, 2020 | Sale | $240.19 | 40,788 | 9,796,779 | 37,685 | Aug 21, 2020, 05:21 PM |
| OYLER JOHN | Chief Executive Officer | Aug 20, 2020 | Sale | $234.62 | 21,523 | 5,049,747 | 20,523 | Aug 21, 2020, 05:21 PM |
| OYLER JOHN | Chief Executive Officer | Aug 19, 2020 | Sale | $234.56 | 29,866 | 7,005,270 | 26,465 | Aug 21, 2020, 05:21 PM |
| AMGEN INC | 10% Owner | Aug 20, 2020 | Option Exercise | $234.99 | 64,176 | 15,080,975 | 18,341,417 | Aug 20, 2020, 07:28 PM |
| AMGEN INC | 10% Owner | Aug 19, 2020 | Option Exercise | $234.88 | 64,176 | 15,073,466 | 18,277,241 | Aug 20, 2020, 07:28 PM |
| AMGEN INC | 10% Owner | Aug 18, 2020 | Option Exercise | $230.18 | 40,000 | 9,207,200 | 18,213,065 | Aug 20, 2020, 07:28 PM |
| OYLER JOHN | Chief Executive Officer | Aug 14, 2020 | Sale | $211.15 | 8,705 | 1,838,037 | 6,407 | Aug 14, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 13, 2020 | Sale | $214.48 | 14,443 | 3,097,763 | 13,762 | Aug 14, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 12, 2020 | Sale | $212.10 | 19,820 | 4,203,769 | 18,720 | Aug 14, 2020, 05:30 PM |
| Chen Timothy Yung-Cheng | Director | Aug 12, 2020 | Option Exercise | $31.59 | 2,897 | 91,516 | 2,897 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 11, 2020 | Option Exercise | $31.59 | 1,903 | 60,116 | 1,903 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 10, 2020 | Option Exercise | $31.59 | 2,200 | 69,498 | 2,200 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 12, 2020 | Sale | $212.00 | 2,897 | 614,164 | 0 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 11, 2020 | Sale | $213.04 | 1,903 | 405,409 | 903 | Aug 12, 2020, 05:02 PM |
| Chen Timothy Yung-Cheng | Director | Aug 10, 2020 | Sale | $214.04 | 2,200 | 470,886 | 1,500 | Aug 12, 2020, 05:02 PM |
| Wang Xiaodong | Director | Aug 10, 2020 | Sale | $211.06 | 4,000 | 844,229 | 2,500 | Aug 12, 2020, 04:38 PM |
| OYLER JOHN | Chief Executive Officer | Aug 05, 2020 | Sale | $223.27 | 17,254 | 3,852,275 | 16,554 | Aug 05, 2020, 05:43 PM |
| OYLER JOHN | Chief Executive Officer | Aug 04, 2020 | Sale | $220.44 | 15,383 | 3,390,953 | 15,100 | Aug 05, 2020, 05:30 PM |
| OYLER JOHN | Chief Executive Officer | Aug 03, 2020 | Sale | $221.78 | 25,176 | 5,583,571 | 25,076 | Aug 05, 2020, 05:30 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2020 | Option Exercise | $94.94 | 3,000 | 284,835 | 3,000 | Jul 31, 2020, 04:24 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2020 | Sale | $209.93 | 3,000 | 629,787 | 1,699 | Jul 31, 2020, 04:24 PM |
| OYLER JOHN | Chief Executive Officer | Jul 22, 2020 | Sale | $238.34 | 27,748 | 6,613,501 | 21,612 | Jul 22, 2020, 06:22 PM |
| OYLER JOHN | Chief Executive Officer | Jul 21, 2020 | Sale | $251.83 | 26,413 | 6,651,693 | 22,003 | Jul 22, 2020, 06:14 PM |
| OYLER JOHN | Chief Executive Officer | Jul 20, 2020 | Sale | $251.85 | 28,762 | 7,243,786 | 28,062 | Jul 22, 2020, 06:14 PM |
| Wang Xiaodong | Director | Jul 20, 2020 | Sale | $251.31 | 12,000 | 3,015,742 | 11,500 | Jul 22, 2020, 04:47 PM |
| Wang Xiaodong | Director | Jul 20, 2020 | Sale | $251.98 | 5,000 | 1,259,896 | 4,700 | Jul 22, 2020, 04:47 PM |
| Wu Xiaobin | President & GM China | Jul 20, 2020 | Sale | $250.16 | 2,600 | 650,408 | 0 | Jul 21, 2020, 04:50 PM |
| Wu Xiaobin | President & GM China | Jul 17, 2020 | Sale | $245.74 | 700 | 172,015 | 400 | Jul 21, 2020, 04:50 PM |
| BAKER BROS. ADVISORS LP | Director | Jul 15, 2020 | Option Exercise | $14.23 | 14,584,180 | 207,544,544 | 18,840,379 | Jul 17, 2020, 05:23 PM |
| AMGEN INC | 10% Owner | Jul 15, 2020 | Option Exercise | $14.23 | 29,614,832 | 421,442,742 | 236,249,845 | Jul 16, 2020, 05:18 PM |
| Wu Xiaobin | President & GM China | Jul 15, 2020 | Sale | $241.11 | 2,700 | 650,998 | 700 | Jul 15, 2020, 05:14 PM |
| Wu Xiaobin | President & GM China | Jul 13, 2020 | Sale | $220.00 | 3,000 | 660,000 | 0 | Jul 15, 2020, 05:14 PM |
| Wang Xiaodong | Director | Jul 07, 2020 | Sale | $200.00 | 6,000 | 1,200,000 | 0 | Jul 09, 2020, 04:45 PM |
| Huang Jane | CMO, Hematology | Jul 07, 2020 | Option Exercise | $160.40 | 3,921 | 628,928 | 3,921 | Jul 09, 2020, 04:43 PM |
| Huang Jane | CMO, Hematology | Jul 07, 2020 | Sale | $200.00 | 3,921 | 784,200 | 0 | Jul 09, 2020, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jul 07, 2020 | Sale | $198.86 | 19,023 | 3,782,991 | 15,293 | Jul 08, 2020, 05:20 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2020 | Sale | $197.11 | 17,362 | 3,422,258 | 16,562 | Jul 08, 2020, 05:20 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2020 | Sale | $201.39 | 17,529 | 3,530,204 | 16,929 | Jul 08, 2020, 05:20 PM |
| Wang Xiaodong | Director | Jul 01, 2020 | Sale | $190.75 | 4,847 | 924,572 | 4,157 | Jul 06, 2020, 04:52 PM |
| OYLER JOHN | Chief Executive Officer | Jul 01, 2020 | Sale | $191.57 | 3,816 | 731,017 | 1,800 | Jul 01, 2020, 04:43 PM |
| OYLER JOHN | Chief Executive Officer | Jun 29, 2020 | Sale | $192.60 | 1,435 | 276,374 | 1,135 | Jul 01, 2020, 04:43 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 29, 2020 | Sale | $191.23 | 300 | 57,368 | 0 | Jul 01, 2020, 04:38 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 26, 2020 | Option Exercise | $160.40 | 2,079 | 333,472 | 2,079 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 29, 2020 | Sale | $190.83 | 1,935 | 369,250 | 1,200 | Jun 30, 2020, 04:14 PM |
| Huang Jane | CMO, Hematology | Jun 26, 2020 | Sale | $200.29 | 2,079 | 416,396 | 1,400 | Jun 30, 2020, 04:14 PM |
| OYLER JOHN | Chief Executive Officer | Jun 24, 2020 | Sale | $187.34 | 14,381 | 2,694,154 | 9,640 | Jun 24, 2020, 08:23 PM |
| OYLER JOHN | Chief Executive Officer | Jun 23, 2020 | Sale | $186.88 | 15,070 | 2,816,221 | 28,761 | Jun 24, 2020, 08:23 PM |
| OYLER JOHN | Chief Executive Officer | Jun 22, 2020 | Sale | $182.43 | 10,281 | 1,875,605 | 38,832 | Jun 24, 2020, 08:23 PM |
| Wang Xiaodong | Director | Jun 23, 2020 | Sale | $186.38 | 6,000 | 1,118,297 | 4,155 | Jun 24, 2020, 08:12 PM |
| Wang Xiaodong | Director | Jun 22, 2020 | Sale | $181.33 | 5,000 | 906,673 | 3,200 | Jun 24, 2020, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Jun 10, 2020 | Sale | $175.07 | 900 | 157,563 | 0 | Jun 12, 2020, 04:14 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 08, 2020 | Sale | $170.84 | 453 | 77,391 | 0 | Jun 10, 2020, 05:17 PM |
| Wu Xiaobin | President & GM China | Jun 08, 2020 | Sale | $170.83 | 2,800 | 478,317 | 1,600 | Jun 10, 2020, 05:15 PM |
| Huang Jane | CMO, Hematology | Jun 08, 2020 | Sale | $170.84 | 631 | 107,800 | 0 | Jun 10, 2020, 05:13 PM |
| Wang Xiaodong | Director | Jun 08, 2020 | Sale | $170.91 | 6,000 | 1,025,456 | 2,500 | Jun 10, 2020, 05:12 PM |
| Huang Jane | CMO, Hematology | May 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jun 02, 2020, 04:11 PM |
| Huang Jane | CMO, Hematology | May 29, 2020 | Sale | $163.86 | 1,500 | 245,784 | 1,000 | Jun 02, 2020, 04:11 PM |
| Glazer Donald W. | Director | May 19, 2020 | Sale | $169.84 | 10,000 | 1,698,400 | 0 | May 21, 2020, 04:08 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2020 | Sale | $141.43 | 4,635 | 655,538 | 3,635 | May 05, 2020, 04:48 PM |
| Wu Xiaobin | President & GM China | May 01, 2020 | Sale | $141.33 | 7,024 | 992,711 | 1,769 | May 05, 2020, 04:46 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Apr 30, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 29, 2020 | Sale | $162.30 | 1,500 | 243,450 | 0 | Apr 30, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 16, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Apr 17, 2020, 04:04 PM |
| Huang Jane | CMO, Hematology | Apr 16, 2020 | Sale | $160.00 | 1,500 | 240,000 | 0 | Apr 17, 2020, 04:04 PM |
| Wang Xiaodong | Director | Mar 04, 2020 | Sale | $157.14 | 5,000 | 785,682 | 1,969 | Mar 06, 2020, 08:30 PM |
| Huang Jane | CMO, Hematology | Feb 18, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Feb 20, 2020, 04:13 PM |
| Huang Jane | CMO, Hematology | Feb 18, 2020 | Sale | $170.25 | 1,500 | 255,380 | 321 | Feb 20, 2020, 04:13 PM |
| Huang Jane | CMO, Hematology | Jan 21, 2020 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Jan 22, 2020, 06:59 PM |
| Huang Jane | CMO, Hematology | Jan 21, 2020 | Sale | $170.70 | 1,500 | 256,043 | 687 | Jan 22, 2020, 06:59 PM |
| OYLER JOHN | Chief Executive Officer | Dec 17, 2019 | Sale | $160.62 | 62,259 | 10,000,110 | 55,204 | Dec 19, 2019, 04:10 PM |
| Huang Jane | CMO, Hematology | Dec 16, 2019 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Dec 18, 2019, 06:57 PM |
| Huang Jane | CMO, Hematology | Dec 16, 2019 | Sale | $165.14 | 1,500 | 247,711 | 1,400 | Dec 18, 2019, 06:57 PM |
| Liang Howard | CFO & Chief Strategy Officer | Nov 18, 2019 | Option Exercise | $6.50 | 25,000 | 162,500 | 25,000 | Nov 20, 2019, 07:20 PM |
| Liang Howard | CFO & Chief Strategy Officer | Nov 18, 2019 | Sale | $194.34 | 25,000 | 4,858,612 | 23,844 | Nov 20, 2019, 07:20 PM |
| Huang Jane | CMO, Hematology | Nov 18, 2019 | Option Exercise | $29.49 | 1,500 | 44,235 | 1,500 | Nov 20, 2019, 07:19 PM |
| Huang Jane | CMO, Hematology | Nov 18, 2019 | Sale | $194.49 | 1,500 | 291,740 | 1,300 | Nov 20, 2019, 07:19 PM |
| Wang Xiaodong | Director | Nov 15, 2019 | Sale | $202.05 | 395 | 79,810 | 0 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 14, 2019 | Sale | $193.57 | 2,605 | 504,242 | 395 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 15, 2019 | Sale | $202.05 | 1,496 | 302,267 | 0 | Nov 18, 2019, 05:24 PM |
| Wang Xiaodong | Director | Nov 14, 2019 | Sale | $193.31 | 8,504 | 1,643,881 | 9,200 | Nov 18, 2019, 05:24 PM |
| Wu Xiaobin | President & GM China | Nov 15, 2019 | Sale | $202.05 | 1,000 | 202,050 | 0 | Nov 18, 2019, 05:22 PM |
| Huang Jane | CMO, Hematology | Nov 04, 2019 | Option Exercise | $29.49 | 32,900 | 970,221 | 32,900 | Nov 06, 2019, 06:51 PM |
| Huang Jane | CMO, Hematology | Nov 04, 2019 | Sale | $190.46 | 32,900 | 6,266,007 | 28,331 | Nov 06, 2019, 06:51 PM |
| Chen Timothy Yung-Cheng | Director | Nov 04, 2019 | Option Exercise | $41.01 | 4,000 | 164,040 | 4,000 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 05, 2019 | Option Exercise | $41.01 | 4,000 | 164,040 | 4,000 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 05, 2019 | Sale | $189.15 | 3,800 | 718,772 | 3,800 | Nov 06, 2019, 06:50 PM |
| Chen Timothy Yung-Cheng | Director | Nov 04, 2019 | Sale | $190.49 | 4,200 | 800,073 | 2,800 | Nov 06, 2019, 06:50 PM |
| Wang Xiaodong | Director | Nov 04, 2019 | Sale | $190.00 | 1,000 | 190,000 | 0 | Nov 05, 2019, 04:22 PM |
| Wang Xiaodong | Director | Nov 01, 2019 | Sale | $170.00 | 1,000 | 170,000 | 0 | Nov 05, 2019, 04:22 PM |
| Wu Xiaobin | President & GM China | Nov 01, 2019 | Sale | $180.00 | 1,000 | 180,000 | 0 | Nov 05, 2019, 04:20 PM |
| Huang Jane | CMO, Hematology | Sep 04, 2019 | Sale | $129.40 | 82 | 10,611 | 0 | Sep 05, 2019, 08:15 PM |
| Huang Jane | CMO, Hematology | Sep 03, 2019 | Sale | $144.45 | 2,862 | 413,419 | 230 | Sep 05, 2019, 08:15 PM |
| Chen Timothy Yung-Cheng | Director | Aug 23, 2019 | Option Exercise | $31.59 | 7,900 | 249,561 | 7,900 | Aug 27, 2019, 04:04 PM |
| Chen Timothy Yung-Cheng | Director | Aug 23, 2019 | Sale | $144.96 | 8,614 | 1,248,682 | 7,614 | Aug 27, 2019, 04:04 PM |
| Huang Jane | CMO, Hematology | Aug 12, 2019 | Option Exercise | $45.31 | 2,500 | 113,275 | 2,500 | Aug 13, 2019, 04:47 PM |
| Huang Jane | CMO, Hematology | Aug 12, 2019 | Sale | $134.74 | 2,500 | 336,855 | 1,700 | Aug 13, 2019, 04:47 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2019 | Option Exercise | $37.30 | 10,130 | 377,834 | 10,130 | Jul 31, 2019, 04:04 PM |
| Huang Jane | CMO, Hematology | Jul 29, 2019 | Sale | $134.54 | 10,130 | 1,362,896 | 7,630 | Jul 31, 2019, 04:04 PM |
| OYLER JOHN | Chief Executive Officer | Jul 08, 2019 | Sale | $126.87 | 3,106 | 394,056 | 1,906 | Jul 09, 2019, 07:23 PM |
| Huang Jane | CMO, Hematology | Jun 27, 2019 | Sale | $124.52 | 430 | 53,542 | 3 | Jul 01, 2019, 08:30 PM |
| Liang Howard | CFO & Chief Strategy Officer | Jun 27, 2019 | Sale | $9.47 | 5,876 | 55,653 | 122,317 | Jul 01, 2019, 08:28 PM |
| Wang Xiaodong | Director | Jul 01, 2019 | Sale | $126.46 | 4,847 | 612,938 | 2,647 | Jul 01, 2019, 08:27 PM |
| Huang Jane | CMO, Hematology | May 21, 2019 | Option Exercise | $45.31 | 2,200 | 99,682 | 2,200 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 20, 2019 | Option Exercise | $45.31 | 300 | 13,593 | 300 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 21, 2019 | Sale | $130.06 | 2,200 | 286,132 | 0 | May 22, 2019, 07:04 PM |
| Huang Jane | CMO, Hematology | May 20, 2019 | Sale | $130.12 | 300 | 39,036 | 0 | May 22, 2019, 07:04 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 21, 2019 | Option Exercise | $6.50 | 23,200 | 150,800 | 23,200 | May 22, 2019, 07:03 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 21, 2019 | Sale | $130.21 | 23,200 | 3,020,872 | 0 | May 22, 2019, 07:03 PM |
| Glazer Donald W. | Director | May 13, 2019 | Sale | $125.11 | 15,027 | 1,880,028 | 0 | May 15, 2019, 03:59 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 06, 2019 | Option Exercise | $6.50 | 1,800 | 11,700 | 1,800 | May 08, 2019, 05:53 PM |
| Liang Howard | CFO & Chief Strategy Officer | May 06, 2019 | Sale | $130.01 | 1,800 | 234,014 | 0 | May 08, 2019, 05:53 PM |
| Wu Xiaobin | President & GM China | May 01, 2019 | Sale | $124.53 | 5,955 | 741,547 | 23,135 | May 02, 2019, 04:08 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2019 | Sale | $125.18 | 2,824 | 353,504 | 1,422 | May 02, 2019, 04:07 PM |
| Huang Jane | CMO, Hematology | Apr 08, 2019 | Option Exercise | $29.49 | 14,130 | 416,694 | 14,130 | Apr 10, 2019, 06:41 PM |
| Huang Jane | CMO, Hematology | Apr 08, 2019 | Sale | $142.77 | 14,130 | 2,017,316 | 13,330 | Apr 10, 2019, 06:41 PM |
| Glazer Donald W. | Director | Mar 14, 2019 | Sale | $136.10 | 14,973 | 2,037,825 | 0 | Mar 18, 2019, 06:30 PM |
| Huang Jane | CMO, Hematology | Mar 11, 2019 | Option Exercise | $29.49 | 2,565 | 75,642 | 2,565 | Mar 11, 2019, 07:38 PM |
| Huang Jane | CMO, Hematology | Mar 11, 2019 | Sale | $130.00 | 2,565 | 333,450 | 0 | Mar 11, 2019, 07:38 PM |
| Huang Jane | CMO, Hematology | Mar 07, 2019 | Sale | $140.50 | 71 | 9,976 | 0 | Mar 11, 2019, 07:38 PM |
| OYLER JOHN | Chief Executive Officer | Mar 06, 2019 | Sale | $150.00 | 100 | 15,000 | 100 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 05, 2019 | Sale | $151.76 | 6,230 | 945,455 | 4,230 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 04, 2019 | Sale | $151.34 | 9,790 | 1,481,625 | 3,700 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 05, 2019 | Sale | $152.25 | 4,791 | 729,432 | 2,558 | Mar 06, 2019, 06:32 PM |
| OYLER JOHN | Chief Executive Officer | Mar 04, 2019 | Sale | $152.01 | 4,588 | 697,425 | 2,086 | Mar 06, 2019, 06:32 PM |
| Wang Xiaodong | Director | Mar 01, 2019 | Sale | $146.03 | 4,000 | 584,125 | 2,700 | Mar 05, 2019, 12:00 AM |
| Wang Xiaodong | Director | Mar 01, 2019 | Sale | $150.00 | 1,000 | 150,000 | 0 | Mar 05, 2019, 12:00 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 18, 2018 | Option Exercise | $29.10 | 10,141 | 295,103 | 10,141 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 17, 2018 | Option Exercise | $29.10 | 9,859 | 286,897 | 9,859 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 18, 2018 | Sale | $133.75 | 10,141 | 1,356,312 | 8,510 | Dec 19, 2018, 06:34 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Dec 17, 2018 | Sale | $133.61 | 9,859 | 1,317,225 | 8,959 | Dec 19, 2018, 06:34 PM |
| OYLER JOHN | Chief Executive Officer | Dec 10, 2018 | Sale | $135.78 | 4,138 | 561,863 | 3,738 | Dec 12, 2018, 05:28 PM |
| Wang Xiaodong | Director | Dec 03, 2018 | Sale | $152.41 | 5,000 | 762,060 | 2,329 | Dec 04, 2018, 05:35 PM |
| OYLER JOHN | Chief Executive Officer | Nov 28, 2018 | Sale | $147.19 | 8,865 | 1,304,863 | 12,503 | Nov 28, 2018, 07:26 PM |
| OYLER JOHN | Chief Executive Officer | Nov 27, 2018 | Sale | $144.57 | 11,252 | 1,626,741 | 24,055 | Nov 28, 2018, 07:26 PM |
| OYLER JOHN | Chief Executive Officer | Nov 26, 2018 | Sale | $139.06 | 9,078 | 1,262,428 | 33,133 | Nov 28, 2018, 07:26 PM |
| Huang Jane | CMO, Hematology | Nov 26, 2018 | Option Exercise | $29.49 | 3,000 | 88,470 | 3,000 | Nov 28, 2018, 07:25 PM |
| Huang Jane | CMO, Hematology | Nov 26, 2018 | Sale | $139.58 | 3,000 | 418,749 | 0 | Nov 28, 2018, 07:25 PM |
| Wang Xiaodong | Director | Nov 19, 2018 | Sale | $124.30 | 5,000 | 621,489 | 3,900 | Nov 21, 2018, 06:41 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 12, 2018 | Option Exercise | $29.10 | 12,067 | 351,150 | 12,067 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 09, 2018 | Option Exercise | $29.10 | 13,222 | 384,760 | 13,222 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 08, 2018 | Option Exercise | $29.10 | 14,711 | 428,090 | 14,711 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 12, 2018 | Sale | $112.73 | 12,067 | 1,360,348 | 9,109 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 09, 2018 | Sale | $120.49 | 13,222 | 1,593,163 | 9,191 | Nov 13, 2018, 10:20 AM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 08, 2018 | Sale | $126.07 | 14,711 | 1,854,578 | 14,245 | Nov 13, 2018, 10:20 AM |
| Huang Jane | CMO, Hematology | Sep 04, 2018 | Sale | $174.60 | 2,911 | 508,246 | 0 | Sep 05, 2018, 05:15 PM |
| Glazer Donald W. | Director | Aug 30, 2018 | Sale | $179.00 | 1,000 | 179,000 | 13,384 | Aug 31, 2018, 04:54 PM |
| Glazer Donald W. | Director | Aug 29, 2018 | Sale | $179.00 | 1,000 | 179,000 | 14,384 | Aug 31, 2018, 04:54 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Aug 23, 2018 | Sale | $169.12 | 5,769 | 975,665 | 4,661 | Aug 24, 2018, 04:25 PM |
| Wang Xiaodong | Director | Aug 13, 2018 | Sale | $158.77 | 3,449 | 547,591 | 1,249 | Aug 15, 2018, 04:23 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 02, 2018 | Buy | $108.00 | 5,814,100 | 627,922,800 | 5,250,491 | Aug 06, 2018, 05:22 PM |
| OYLER JOHN | Chief Executive Officer | Jul 16, 2018 | Sale | $164.12 | 2,550 | 418,498 | 0 | Jul 17, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 19, 2018 | Option Exercise | $6.50 | 24,128 | 156,832 | 29,128 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 16, 2018 | Option Exercise | $6.50 | 10,872 | 70,668 | 15,872 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 19, 2018 | Sale | $161.46 | 29,128 | 4,702,982 | 28,628 | Mar 20, 2018, 05:02 PM |
| Liang Howard | CFO & Chief Strategy Officer | Mar 16, 2018 | Sale | $157.07 | 10,872 | 1,707,669 | 14,872 | Mar 20, 2018, 05:02 PM |
| OYLER JOHN | Chief Executive Officer | Feb 28, 2018 | Sale | $146.69 | 34,338 | 5,036,940 | 93,883 | Mar 02, 2018, 06:42 PM |
| OYLER JOHN | Chief Executive Officer | Mar 02, 2018 | Sale | $148.13 | 25,362 | 3,756,785 | 24,062 | Mar 02, 2018, 06:42 PM |
| OYLER JOHN | Chief Executive Officer | Mar 01, 2018 | Sale | $143.08 | 39,300 | 5,623,203 | 62,062 | Mar 02, 2018, 06:42 PM |
| Li Ji | EVP and Gl. Head of Bus. Dev. | Feb 28, 2018 | Option Exercise | $26.65 | 10,000 | 266,500 | 10,000 | Mar 02, 2018, 06:41 PM |
| Li Ji | EVP and Gl. Head of Bus. Dev. | Feb 28, 2018 | Sale | $146.88 | 10,000 | 1,468,761 | 8,251 | Mar 02, 2018, 06:41 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 18, 2018 | Buy | $101.00 | 1,980,198 | 199,999,998 | 5,121,404 | Jan 22, 2018, 05:03 PM |
| OYLER JOHN | Chief Executive Officer | Dec 26, 2017 | Sale | $96.46 | 20,137 | 1,942,515 | 110,179 | Dec 28, 2017, 05:49 PM |
| Huang Jane | CMO, Hematology | Dec 21, 2017 | Option Exercise | $29.51 | 1,000 | 29,510 | 1,000 | Dec 22, 2017, 04:43 PM |
| Huang Jane | CMO, Hematology | Dec 21, 2017 | Sale | $98.00 | 1,000 | 98,000 | 0 | Dec 22, 2017, 04:43 PM |
| Huang Jane | CMO, Hematology | Dec 13, 2017 | Option Exercise | $29.51 | 1,500 | 44,265 | 1,500 | Dec 15, 2017, 04:05 PM |
| Huang Jane | CMO, Hematology | Dec 13, 2017 | Sale | $94.25 | 1,500 | 141,381 | 200 | Dec 15, 2017, 04:05 PM |
| OYLER JOHN | Chief Executive Officer | Dec 08, 2017 | Sale | $95.57 | 52,817 | 5,047,758 | 161,145 | Dec 08, 2017, 05:57 PM |
| OYLER JOHN | Chief Executive Officer | Dec 07, 2017 | Sale | $93.40 | 59,737 | 5,579,304 | 207,611 | Dec 08, 2017, 05:57 PM |
| OYLER JOHN | Chief Executive Officer | Dec 06, 2017 | Sale | $92.29 | 31,446 | 2,902,224 | 255,137 | Dec 08, 2017, 05:57 PM |
| Huang Jane | CMO, Hematology | Dec 04, 2017 | Sale | $86.00 | 1,100 | 94,600 | 0 | Dec 05, 2017, 09:15 AM |
| OYLER JOHN | Chief Executive Officer | Nov 28, 2017 | Sale | $85.52 | 32,985 | 2,820,864 | 299,477 | Nov 29, 2017, 05:33 PM |
| OYLER JOHN | Chief Executive Officer | Nov 27, 2017 | Sale | $86.76 | 16,581 | 1,438,582 | 332,697 | Nov 29, 2017, 05:33 PM |
| OYLER JOHN | Chief Executive Officer | Nov 29, 2017 | Sale | $82.92 | 36,340 | 3,013,458 | 263,137 | Nov 29, 2017, 05:33 PM |
| Huang Jane | CMO, Hematology | Nov 20, 2017 | Sale | $87.00 | 1,000 | 87,000 | 1,100 | Nov 20, 2017, 05:14 PM |
| Huang Jane | CMO, Hematology | Nov 16, 2017 | Sale | $85.00 | 600 | 51,000 | 2,100 | Nov 20, 2017, 05:14 PM |
| OYLER JOHN | Chief Executive Officer | Nov 13, 2017 | Sale | $83.06 | 25,054 | 2,080,916 | 491,891 | Nov 15, 2017, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Nov 15, 2017 | Sale | $80.23 | 66,068 | 5,300,508 | 411,313 | Nov 15, 2017, 08:12 PM |
| OYLER JOHN | Chief Executive Officer | Nov 14, 2017 | Sale | $79.74 | 59,835 | 4,770,950 | 435,618 | Nov 15, 2017, 08:12 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Nov 13, 2017 | Sale | $82.96 | 3,601 | 298,747 | 1,201 | Nov 15, 2017, 08:11 PM |
| Peterson Amy C. | CMO, Immuno-oncology | Aug 22, 2017 | Option Exercise | $5.39 | 28,185 | 151,830 | 271,815 | Aug 24, 2017, 04:20 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 11, 2017 | Buy | $71.00 | 176,056 | 12,499,976 | 3,476,256 | Aug 14, 2017, 03:49 PM |
| Wang Xiaodong | Director | Jul 12, 2017 | Sale | $72.44 | 20,000 | 1,448,704 | 16,300 | Jul 13, 2017, 06:31 PM |
| Glazer Donald W. | Director | Jul 10, 2017 | Sale | $72.15 | 10,810 | 779,900 | 7,206 | Jul 12, 2017, 09:37 PM |
| OYLER JOHN | Chief Executive Officer | Jul 06, 2017 | Sale | $64.82 | 219,400 | 14,221,125 | 212,055 | Jul 10, 2017, 06:44 PM |
| Wang Xiaodong | Director | Jun 28, 2017 | Sale | $44.95 | 35,000 | 1,573,345 | 26,600 | Jun 30, 2017, 04:36 PM |
| OYLER JOHN | Chief Executive Officer | Jun 23, 2017 | Sale | $44.28 | 39,895 | 1,766,353 | 62,321 | Jun 26, 2017, 08:38 PM |
| OYLER JOHN | Chief Executive Officer | Jun 22, 2017 | Sale | $44.08 | 58,605 | 2,583,269 | 88,535 | Jun 26, 2017, 08:38 PM |
| Wang Xiaodong | Director | Jun 02, 2017 | Sale | $40.00 | 5,539 | 221,560 | 55,000 | Jun 06, 2017, 04:20 PM |
| Wang Xiaodong | Director | May 04, 2017 | Sale | $41.01 | 4,491 | 184,171 | 60,539 | May 05, 2017, 05:50 PM |
| Wang Xiaodong | Director | May 03, 2017 | Sale | $40.71 | 9,970 | 405,871 | 65,030 | May 05, 2017, 05:50 PM |
| OYLER JOHN | Chief Executive Officer | May 01, 2017 | Sale | $42.02 | 2,100 | 88,243 | 145,340 | May 01, 2017, 07:44 PM |
| OYLER JOHN | Chief Executive Officer | Apr 27, 2017 | Sale | $40.37 | 34,049 | 1,374,565 | 147,440 | May 01, 2017, 07:44 PM |
| Wang Xiaodong | Director | Apr 05, 2017 | Sale | $36.83 | 11,650 | 429,085 | 81,194 | Apr 07, 2017, 05:10 PM |
| Wang Xiaodong | Director | Mar 24, 2017 | Sale | $36.60 | 18,787 | 687,634 | 86,850 | Mar 24, 2017, 06:57 PM |
| Wang Xiaodong | Director | Mar 23, 2017 | Sale | $36.99 | 11,041 | 408,462 | 105,437 | Mar 24, 2017, 06:57 PM |
| Wang Xiaodong | Director | Mar 22, 2017 | Sale | $37.75 | 8,279 | 312,517 | 116,478 | Mar 24, 2017, 06:57 PM |
| OYLER JOHN | Chief Executive Officer | Mar 20, 2017 | Sale | $40.02 | 13,234 | 529,611 | 181,489 | Mar 20, 2017, 07:06 PM |
| OYLER JOHN | Chief Executive Officer | Mar 17, 2017 | Sale | $40.02 | 2,717 | 108,737 | 194,723 | Mar 20, 2017, 07:06 PM |
| OYLER JOHN | Chief Executive Officer | Mar 16, 2017 | Sale | $38.77 | 16,038 | 621,725 | 197,640 | Mar 20, 2017, 07:06 PM |
| Wang Xiaodong | Director | Mar 10, 2017 | Sale | $39.94 | 7,304 | 291,702 | 124,757 | Mar 10, 2017, 07:16 PM |
| Wang Xiaodong | Director | Mar 09, 2017 | Sale | $39.95 | 18,596 | 742,843 | 132,061 | Mar 10, 2017, 07:16 PM |
| Wang Xiaodong | Director | Mar 08, 2017 | Sale | $39.78 | 10,992 | 437,211 | 150,657 | Mar 10, 2017, 07:16 PM |
| OYLER JOHN | Chief Executive Officer | Mar 03, 2017 | Sale | $40.83 | 40,091 | 1,636,968 | 241,794 | Mar 06, 2017, 07:00 PM |
| OYLER JOHN | Chief Executive Officer | Mar 02, 2017 | Sale | $41.25 | 49,092 | 2,025,104 | 273,385 | Mar 06, 2017, 07:00 PM |
| OYLER JOHN | Chief Executive Officer | Mar 06, 2017 | Sale | $40.23 | 19,816 | 797,258 | 217,708 | Mar 06, 2017, 07:00 PM |
| Wang Xiaodong | Director | Feb 27, 2017 | Sale | $38.10 | 4,444 | 169,328 | 161,649 | Feb 27, 2017, 09:11 PM |
| Wang Xiaodong | Director | Feb 24, 2017 | Sale | $38.14 | 28,402 | 1,083,114 | 166,593 | Feb 27, 2017, 09:11 PM |
| Wang Xiaodong | Director | Feb 23, 2017 | Sale | $38.57 | 5,505 | 212,351 | 194,495 | Feb 27, 2017, 09:11 PM |
| OYLER JOHN | Chief Executive Officer | Feb 17, 2017 | Sale | $40.67 | 7,204 | 292,981 | 332,836 | Feb 21, 2017, 07:23 PM |
| OYLER JOHN | Chief Executive Officer | Feb 16, 2017 | Sale | $40.65 | 47,400 | 1,926,867 | 378,383 | Feb 21, 2017, 07:23 PM |
| OYLER JOHN | Chief Executive Officer | Feb 21, 2017 | Sale | $39.98 | 10,359 | 414,162 | 325,410 | Feb 21, 2017, 07:23 PM |
| Wang Xiaodong | Director | Nov 23, 2016 | Sale | $32.00 | 93,750 | 3,000,000 | 0 | Nov 28, 2016, 04:04 PM |
| Malley Thomas | Director | Nov 23, 2016 | Buy | $32.00 | 30,000 | 960,000 | 30,000 | Nov 28, 2016, 04:02 PM |
| BAKER BROS. ADVISORS LP | Director | Nov 18, 2016 | Buy | $32.00 | 1,760,495 | 56,335,840 | 3,317,977 | Nov 21, 2016, 06:13 PM |
| Glazer Donald W. | Director | Sep 28, 2016 | Sale | $30.66 | 41,463 | 1,271,175 | 11,300 | Sep 30, 2016, 04:50 PM |
| Glazer Donald W. | Director | Sep 26, 2016 | Sale | $29.58 | 20,666 | 611,300 | 67,946 | Sep 28, 2016, 04:11 PM |
| Glazer Donald W. | Director | Sep 27, 2016 | Sale | $29.63 | 26,483 | 784,691 | 41,463 | Sep 28, 2016, 04:11 PM |
| Glazer Donald W. | Director | Sep 23, 2016 | Sale | $30.77 | 11,433 | 351,793 | 88,612 | Sep 26, 2016, 06:12 PM |
| Glazer Donald W. | Director | Sep 22, 2016 | Sale | $31.13 | 25,010 | 778,561 | 100,045 | Sep 26, 2016, 06:12 PM |
| Glazer Donald W. | Director | Sep 21, 2016 | Sale | $31.19 | 16,318 | 508,958 | 125,055 | Sep 21, 2016, 09:11 PM |
| Glazer Donald W. | Director | Sep 20, 2016 | Sale | $31.01 | 8,243 | 255,615 | 141,373 | Sep 21, 2016, 09:11 PM |
| Glazer Donald W. | Director | Sep 19, 2016 | Sale | $31.59 | 42,691 | 1,348,487 | 151,516 | Sep 21, 2016, 09:11 PM |
| Liang Howard | CFO & Chief Strategy Officer | Feb 08, 2016 | Buy | $1.85 | 65,000 | 120,250 | 65,000 | Feb 09, 2016, 08:08 PM |
| Yuan RuiRong | Chief Medical Officer | Feb 08, 2016 | Buy | $1.85 | 130,000 | 240,500 | 130,000 | Feb 09, 2016, 08:08 PM |
| BAKER BROS. ADVISORS LP | Director | Feb 08, 2016 | Buy | $24.00 | 1,912,680 | 45,904,320 | 1,723,306 | Feb 09, 2016, 05:38 PM |
| BAKER BROS. ADVISORS LP | Director | Feb 08, 2016 | Option Exercise | $0.68 | 2,592,593 | 1,750,000 | 73,162,022 | Feb 09, 2016, 05:38 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 198,550,000 |
| Lee Chan Henry | SVP, General Counsel | 07/31/2023 | 171,059 |
| Wang Julia Aijun | Chief Financial Officer | 07/03/2023 | 84,747 |
| Wang Lai | Global Head of R&D | 06/26/2023 | 201,567 |
| Wang Julia Aijun | Chief Financial Officer | 06/23/2023 | 153,594 |
| Sanders Corazon (Corsee) D. | Director | 06/23/2023 | 105,381 |
| Wu Xiaobin | President, COO & GM China | 06/26/2023 | 272,636 |
| Wang Lai | Global Head of R&D | 06/20/2023 | 254,955 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/13/2023 | 169,448,350 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/14/2023 | 56,857,987 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/12/2023 | 244,057,184 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/09/2023 | 99,244,888 |
| HHLR ADVISORS, LTD. | 10% Owner | 06/08/2023 | 253,881,793 |
| Wang Lai | Global Head of R&D | 06/07/2023 | 103,828 |
| Wu Xiaobin | President, COO & GM China | 06/07/2023 | 739,599 |
| Wu Xiaobin | President, COO & GM China | 05/08/2023 | 1,776,037 |
| Wang Xiaodong | Director | 03/08/2023 | 8,793 |
| Wang Xiaodong | Director | 03/08/2023 | 15,287,339 |
| Wang Xiaodong | Director | 01/12/2023 | 1,302,585 |
| OYLER JOHN | Chief Executive Officer | 01/10/2023 | 3,378,292 |
| OYLER JOHN | Chief Executive Officer | 01/10/2023 | 1,689,157 |
| Wang Xiaodong | Director | 01/10/2023 | 400,152 |
| Wang Xiaodong | Director | 01/09/2023 | 225,000 |
| Wang Xiaodong | Director | 01/11/2023 | 631,647 |
| OYLER JOHN | Chief Executive Officer | 12/27/2022 | 502,193 |
| OYLER JOHN | Chief Executive Officer | 12/27/2022 | 251,209 |
| OYLER JOHN | Chief Executive Officer | 12/29/2022 | 770,798 |
| OYLER JOHN | Chief Executive Officer | 12/29/2022 | 385,174 |
| OYLER JOHN | Chief Executive Officer | 12/28/2022 | 164,724 |
| OYLER JOHN | Chief Executive Officer | 12/28/2022 | 82,474 |
| Wang Xiaodong | Director | 12/13/2022 | 636,724 |
| Wang Xiaodong | Director | 11/15/2022 | 417,542 |
| OYLER JOHN | Chief Executive Officer | 11/15/2022 | 1,019,229 |
| OYLER JOHN | Chief Executive Officer | 11/15/2022 | 5,171,104 |
| OYLER JOHN | Chief Executive Officer | 09/20/2022 | 4,684,837 |
| OYLER JOHN | Chief Executive Officer | 09/21/2022 | 2,921,712 |
| Wang Xiaodong | Director | 08/08/2022 | 1,219,594 |
| Wang Xiaodong | Director | 08/05/2022 | 969,256 |
| Wang Xiaodong | Director | 08/05/2022 | 969,272 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2022 | 50,245 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2022 | 46,758 |
| Wang Lai | Global Head of R&D | 06/27/2022 | 81,215 |
| Wang Lai | Global Head of R&D | 06/21/2022 | 107,734 |
| Wang Lai | Global Head of R&D | 06/17/2022 | 62,034 |
| Wu Xiaobin | President, COO & GM China | 06/21/2022 | 145,804 |
| Wu Xiaobin | President, COO & GM China | 06/17/2022 | 80,691 |
| Wang Julia Aijun | Chief Financial Officer | 06/17/2022 | 21,999 |
| Wang Lai | Global Head of R&D | 06/06/2022 | 93,717 |
| Wu Xiaobin | President, COO & GM China | 06/06/2022 | 484,203 |
| Wang Lai | Global Head of R&D | 05/17/2022 | 4,025,737 |
| Wu Xiaobin | President, COO & GM China | 05/05/2022 | 1,105,275 |
| Huang Jane | CMO, Hematology | 12/14/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 12/14/2021 | 417,211 |
| Huang Jane | CMO, Hematology | 12/01/2021 | 377,493 |
| Huang Jane | CMO, Hematology | 11/17/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 11/17/2021 | 572,003 |
| Wang Xiaodong | Director | 11/08/2021 | 1,575,202 |
| Wang Xiaodong | Director | 11/08/2021 | 1,574,148 |
| Wu Xiaobin | President, COO & GM China | 11/09/2021 | 855,038 |
| Wu Xiaobin | President, COO & GM China | 11/08/2021 | 2,727,625 |
| Huang Jane | CMO, Hematology | 10/19/2021 | 179,940 |
| Huang Jane | CMO, Hematology | 10/19/2021 | 559,163 |
| Huang Jane | CMO, Hematology | 09/20/2021 | 719,760 |
| Huang Jane | CMO, Hematology | 09/20/2021 | 2,387,774 |
| OYLER JOHN | Chief Executive Officer | 09/15/2021 | 15,439,460 |
| OYLER JOHN | Chief Executive Officer | 09/14/2021 | 18,348,858 |
| Huang Jane | CMO, Hematology | 09/13/2021 | 4,620,392 |
| AMGEN INC | 10% Owner | 09/10/2021 | 49,999,856 |
| OYLER JOHN | Chief Executive Officer | 09/02/2021 | 8,040,809 |
| OYLER JOHN | Chief Executive Officer | 09/01/2021 | 11,411,639 |
| OYLER JOHN | Chief Executive Officer | 08/31/2021 | 12,232,867 |
| Huang Jane | CMO, Hematology | 09/02/2021 | 178,314 |
| Huang Jane | CMO, Hematology | 09/01/2021 | 168,307 |
| OYLER JOHN | Chief Executive Officer | 08/04/2021 | 12,205,592 |
| OYLER JOHN | Chief Executive Officer | 08/05/2021 | 4,378,046 |
| OYLER JOHN | Chief Executive Officer | 08/03/2021 | 15,202,040 |
| OYLER JOHN | Chief Executive Officer | 07/22/2021 | 4,971,359 |
| OYLER JOHN | Chief Executive Officer | 07/21/2021 | 4,999,824 |
| OYLER JOHN | Chief Executive Officer | 07/20/2021 | 5,779,054 |
| Huang Jane | CMO, Hematology | 07/15/2021 | 3,085,002 |
| Huang Jane | CMO, Hematology | 07/15/2021 | 6,980,771 |
| OYLER JOHN | Chief Executive Officer | 07/07/2021 | 97,570 |
| OYLER JOHN | Chief Executive Officer | 07/08/2021 | 6,301,730 |
| OYLER JOHN | Chief Executive Officer | 07/07/2021 | 9,139,023 |
| OYLER JOHN | Chief Executive Officer | 07/06/2021 | 5,375,612 |
| Wu Xiaobin | President, COO & GM China | 07/06/2021 | 3,313,928 |
| Wang Xiaodong | Director | 07/01/2021 | 1,687,852 |
| Wang Julia Aijun | Chief Financial Officer | 07/01/2021 | 107,512 |
| Huang Jane | CMO, Hematology | 06/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 06/29/2021 | 528,198 |
| Huang Jane | CMO, Hematology | 06/28/2021 | 155,125 |
| Wang Lai | Global Head of R&D | 06/28/2021 | 164,930 |
| Liang Howard | CFO & Chief Strategy Officer | 06/28/2021 | 162,790 |
| Huang Jane | CMO, Hematology | 06/18/2021 | 152,733 |
| Chen Timothy Yung-Cheng | Director | 06/10/2021 | 89,589 |
| Chen Timothy Yung-Cheng | Director | 06/09/2021 | 99,951 |
| Chen Timothy Yung-Cheng | Director | 06/10/2021 | 998,348 |
| Chen Timothy Yung-Cheng | Director | 06/09/2021 | 1,111,669 |
| Wu Xiaobin | President, COO & GM China | 06/07/2021 | 1,197,918 |
| Huang Jane | CMO, Hematology | 06/07/2021 | 211,986 |
| Wang Xiaodong | Director | 05/10/2021 | 6,175 |
| Wang Xiaodong | Director | 05/10/2021 | 1,019,751 |
| Huang Jane | CMO, Hematology | 04/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 04/29/2021 | 532,387 |
| Huang Jane | CMO, Hematology | 03/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 03/29/2021 | 485,993 |
| Huang Jane | CMO, Hematology | 02/26/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 02/26/2021 | 481,099 |
| Huang Jane | CMO, Hematology | 01/29/2021 | 44,235 |
| Huang Jane | CMO, Hematology | 01/29/2021 | 484,492 |
| Liang Howard | CFO & Chief Strategy Officer | 01/14/2021 | 9,100 |
| Liang Howard | CFO & Chief Strategy Officer | 01/15/2021 | 81,900 |
| Liang Howard | CFO & Chief Strategy Officer | 01/14/2021 | 482,256 |
| Liang Howard | CFO & Chief Strategy Officer | 01/15/2021 | 4,345,687 |
| BAKER BROS. ADVISORS LP | Director | 01/04/2021 | 26,714,457 |
| Huang Jane | CMO, Hematology | 12/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 12/29/2020 | 373,690 |
| AMGEN INC | 10% Owner | 12/18/2020 | 6,722,516 |
| AMGEN INC | 10% Owner | 12/16/2020 | 21,244,439 |
| AMGEN INC | 10% Owner | 12/15/2020 | 16,258,757 |
| AMGEN INC | 10% Owner | 12/17/2020 | 19,442,538 |
| Liang Howard | CFO & Chief Strategy Officer | 12/14/2020 | 1,300,000 |
| Liang Howard | CFO & Chief Strategy Officer | 12/14/2020 | 21,048,471 |
| BAKER BROS. ADVISORS LP | Director | 12/04/2020 | 333,295,893 |
| Huang Jane | CMO, Hematology | 11/30/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 11/30/2020 | 401,722 |
| Huang Jane | CMO, Hematology | 10/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 10/29/2020 | 450,092 |
| Wang Xiaodong | Director | 10/16/2020 | 1,600,000 |
| Wang Xiaodong | Director | 10/05/2020 | 1,500,000 |
| Wu Xiaobin | President & GM China | 10/05/2020 | 1,200,000 |
| Liang Howard | CFO & Chief Strategy Officer | 10/05/2020 | 91,000 |
| Liang Howard | CFO & Chief Strategy Officer | 10/05/2020 | 4,194,415 |
| Huang Jane | CMO, Hematology | 09/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 09/29/2020 | 420,568 |
| OYLER JOHN | Chief Executive Officer | 09/29/2020 | 6,544,031 |
| OYLER JOHN | Chief Executive Officer | 09/28/2020 | 8,682,061 |
| Wang Xiaodong | Director | 09/25/2020 | 1,402,117 |
| Wu Xiaobin | President & GM China | 09/25/2020 | 1,121,408 |
| Wang Xiaodong | Director | 09/17/2020 | 1,301,358 |
| Wu Xiaobin | President & GM China | 09/17/2020 | 1,041,326 |
| OYLER JOHN | Chief Executive Officer | 09/16/2020 | 6,948,803 |
| OYLER JOHN | Chief Executive Officer | 09/15/2020 | 8,699,382 |
| OYLER JOHN | Chief Executive Officer | 09/14/2020 | 4,939,776 |
| Liang Howard | CFO & Chief Strategy Officer | 09/14/2020 | 91,000 |
| Liang Howard | CFO & Chief Strategy Officer | 09/14/2020 | 3,503,765 |
| Huang Jane | CMO, Hematology | 09/03/2020 | 729,044 |
| OYLER JOHN | Chief Executive Officer | 09/02/2020 | 6,374,025 |
| OYLER JOHN | Chief Executive Officer | 09/01/2020 | 4,739,812 |
| OYLER JOHN | Chief Executive Officer | 08/31/2020 | 3,121,766 |
| Huang Jane | CMO, Hematology | 08/28/2020 | 88,470 |
| Huang Jane | CMO, Hematology | 08/28/2020 | 726,627 |
| AMGEN INC | 10% Owner | 08/25/2020 | 14,757,583 |
| AMGEN INC | 10% Owner | 08/24/2020 | 14,199,911 |
| AMGEN INC | 10% Owner | 08/21/2020 | 14,772,031 |
| OYLER JOHN | Chief Executive Officer | 08/21/2020 | 9,796,779 |
| OYLER JOHN | Chief Executive Officer | 08/20/2020 | 5,049,747 |
| OYLER JOHN | Chief Executive Officer | 08/19/2020 | 7,005,270 |
| AMGEN INC | 10% Owner | 08/20/2020 | 15,080,975 |
| AMGEN INC | 10% Owner | 08/19/2020 | 15,073,466 |
| AMGEN INC | 10% Owner | 08/18/2020 | 9,207,200 |
| OYLER JOHN | Chief Executive Officer | 08/14/2020 | 1,838,037 |
| OYLER JOHN | Chief Executive Officer | 08/13/2020 | 3,097,763 |
| OYLER JOHN | Chief Executive Officer | 08/12/2020 | 4,203,769 |
| Chen Timothy Yung-Cheng | Director | 08/12/2020 | 91,516 |
| Chen Timothy Yung-Cheng | Director | 08/11/2020 | 60,116 |
| Chen Timothy Yung-Cheng | Director | 08/10/2020 | 69,498 |
| Chen Timothy Yung-Cheng | Director | 08/12/2020 | 614,164 |
| Chen Timothy Yung-Cheng | Director | 08/11/2020 | 405,409 |
| Chen Timothy Yung-Cheng | Director | 08/10/2020 | 470,886 |
| Wang Xiaodong | Director | 08/10/2020 | 844,229 |
| OYLER JOHN | Chief Executive Officer | 08/05/2020 | 3,852,275 |
| OYLER JOHN | Chief Executive Officer | 08/04/2020 | 3,390,953 |
| OYLER JOHN | Chief Executive Officer | 08/03/2020 | 5,583,571 |
| Huang Jane | CMO, Hematology | 07/29/2020 | 284,835 |
| Huang Jane | CMO, Hematology | 07/29/2020 | 629,787 |
| OYLER JOHN | Chief Executive Officer | 07/22/2020 | 6,613,501 |
| OYLER JOHN | Chief Executive Officer | 07/21/2020 | 6,651,693 |
| OYLER JOHN | Chief Executive Officer | 07/20/2020 | 7,243,786 |
| Wang Xiaodong | Director | 07/20/2020 | 3,015,742 |
| Wang Xiaodong | Director | 07/20/2020 | 1,259,896 |
| Wu Xiaobin | President & GM China | 07/20/2020 | 650,408 |
| Wu Xiaobin | President & GM China | 07/17/2020 | 172,015 |
| BAKER BROS. ADVISORS LP | Director | 07/15/2020 | 207,544,544 |
| AMGEN INC | 10% Owner | 07/15/2020 | 421,442,742 |
| Wu Xiaobin | President & GM China | 07/15/2020 | 650,998 |
| Wu Xiaobin | President & GM China | 07/13/2020 | 660,000 |
| Wang Xiaodong | Director | 07/07/2020 | 1,200,000 |
| Huang Jane | CMO, Hematology | 07/07/2020 | 628,928 |
| Huang Jane | CMO, Hematology | 07/07/2020 | 784,200 |
| OYLER JOHN | Chief Executive Officer | 07/07/2020 | 3,782,991 |
| OYLER JOHN | Chief Executive Officer | 07/06/2020 | 3,422,258 |
| OYLER JOHN | Chief Executive Officer | 07/08/2020 | 3,530,204 |
| Wang Xiaodong | Director | 07/01/2020 | 924,572 |
| OYLER JOHN | Chief Executive Officer | 07/01/2020 | 731,017 |
| OYLER JOHN | Chief Executive Officer | 06/29/2020 | 276,374 |
| Liang Howard | CFO & Chief Strategy Officer | 06/29/2020 | 57,368 |
| Huang Jane | CMO, Hematology | 06/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 06/26/2020 | 333,472 |
| Huang Jane | CMO, Hematology | 06/29/2020 | 369,250 |
| Huang Jane | CMO, Hematology | 06/26/2020 | 416,396 |
| OYLER JOHN | Chief Executive Officer | 06/24/2020 | 2,694,154 |
| OYLER JOHN | Chief Executive Officer | 06/23/2020 | 2,816,221 |
| OYLER JOHN | Chief Executive Officer | 06/22/2020 | 1,875,605 |
| Wang Xiaodong | Director | 06/23/2020 | 1,118,297 |
| Wang Xiaodong | Director | 06/22/2020 | 906,673 |
| OYLER JOHN | Chief Executive Officer | 06/10/2020 | 157,563 |
| Liang Howard | CFO & Chief Strategy Officer | 06/08/2020 | 77,391 |
| Wu Xiaobin | President & GM China | 06/08/2020 | 478,317 |
| Huang Jane | CMO, Hematology | 06/08/2020 | 107,800 |
| Wang Xiaodong | Director | 06/08/2020 | 1,025,456 |
| Huang Jane | CMO, Hematology | 05/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 05/29/2020 | 245,784 |
| Glazer Donald W. | Director | 05/19/2020 | 1,698,400 |
| OYLER JOHN | Chief Executive Officer | 05/01/2020 | 655,538 |
| Wu Xiaobin | President & GM China | 05/01/2020 | 992,711 |
| Huang Jane | CMO, Hematology | 04/29/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 04/29/2020 | 243,450 |
| Huang Jane | CMO, Hematology | 04/16/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 04/16/2020 | 240,000 |
| Wang Xiaodong | Director | 03/04/2020 | 785,682 |
| Huang Jane | CMO, Hematology | 02/18/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 02/18/2020 | 255,380 |
| Huang Jane | CMO, Hematology | 01/21/2020 | 44,235 |
| Huang Jane | CMO, Hematology | 01/21/2020 | 256,043 |
| OYLER JOHN | Chief Executive Officer | 12/17/2019 | 10,000,110 |
| Huang Jane | CMO, Hematology | 12/16/2019 | 44,235 |
| Huang Jane | CMO, Hematology | 12/16/2019 | 247,711 |
| Liang Howard | CFO & Chief Strategy Officer | 11/18/2019 | 162,500 |
| Liang Howard | CFO & Chief Strategy Officer | 11/18/2019 | 4,858,612 |
| Huang Jane | CMO, Hematology | 11/18/2019 | 44,235 |
| Huang Jane | CMO, Hematology | 11/18/2019 | 291,740 |
| Wang Xiaodong | Director | 11/15/2019 | 79,810 |
| Wang Xiaodong | Director | 11/14/2019 | 504,242 |
| Wang Xiaodong | Director | 11/15/2019 | 302,267 |
| Wang Xiaodong | Director | 11/14/2019 | 1,643,881 |
| Wu Xiaobin | President & GM China | 11/15/2019 | 202,050 |
| Huang Jane | CMO, Hematology | 11/04/2019 | 970,221 |
| Huang Jane | CMO, Hematology | 11/04/2019 | 6,266,007 |
| Chen Timothy Yung-Cheng | Director | 11/04/2019 | 164,040 |
| Chen Timothy Yung-Cheng | Director | 11/05/2019 | 164,040 |
| Chen Timothy Yung-Cheng | Director | 11/05/2019 | 718,772 |
| Chen Timothy Yung-Cheng | Director | 11/04/2019 | 800,073 |
| Wang Xiaodong | Director | 11/04/2019 | 190,000 |
| Wang Xiaodong | Director | 11/01/2019 | 170,000 |
| Wu Xiaobin | President & GM China | 11/01/2019 | 180,000 |
| Huang Jane | CMO, Hematology | 09/04/2019 | 10,611 |
| Huang Jane | CMO, Hematology | 09/03/2019 | 413,419 |
| Chen Timothy Yung-Cheng | Director | 08/23/2019 | 249,561 |
| Chen Timothy Yung-Cheng | Director | 08/23/2019 | 1,248,682 |
| Huang Jane | CMO, Hematology | 08/12/2019 | 113,275 |
| Huang Jane | CMO, Hematology | 08/12/2019 | 336,855 |
| Huang Jane | CMO, Hematology | 07/29/2019 | 377,834 |
| Huang Jane | CMO, Hematology | 07/29/2019 | 1,362,896 |
| OYLER JOHN | Chief Executive Officer | 07/08/2019 | 394,056 |
| Huang Jane | CMO, Hematology | 06/27/2019 | 53,542 |
| Liang Howard | CFO & Chief Strategy Officer | 06/27/2019 | 55,653 |
| Wang Xiaodong | Director | 07/01/2019 | 612,938 |
| Huang Jane | CMO, Hematology | 05/21/2019 | 99,682 |
| Huang Jane | CMO, Hematology | 05/20/2019 | 13,593 |
| Huang Jane | CMO, Hematology | 05/21/2019 | 286,132 |
| Huang Jane | CMO, Hematology | 05/20/2019 | 39,036 |
| Liang Howard | CFO & Chief Strategy Officer | 05/21/2019 | 150,800 |
| Liang Howard | CFO & Chief Strategy Officer | 05/21/2019 | 3,020,872 |
| Glazer Donald W. | Director | 05/13/2019 | 1,880,028 |
| Liang Howard | CFO & Chief Strategy Officer | 05/06/2019 | 11,700 |
| Liang Howard | CFO & Chief Strategy Officer | 05/06/2019 | 234,014 |
| Wu Xiaobin | President & GM China | 05/01/2019 | 741,547 |
| OYLER JOHN | Chief Executive Officer | 05/01/2019 | 353,504 |
| Huang Jane | CMO, Hematology | 04/08/2019 | 416,694 |
| Huang Jane | CMO, Hematology | 04/08/2019 | 2,017,316 |
| Glazer Donald W. | Director | 03/14/2019 | 2,037,825 |
| Huang Jane | CMO, Hematology | 03/11/2019 | 75,642 |
| Huang Jane | CMO, Hematology | 03/11/2019 | 333,450 |
| Huang Jane | CMO, Hematology | 03/07/2019 | 9,976 |
| OYLER JOHN | Chief Executive Officer | 03/06/2019 | 15,000 |
| OYLER JOHN | Chief Executive Officer | 03/05/2019 | 945,455 |
| OYLER JOHN | Chief Executive Officer | 03/04/2019 | 1,481,625 |
| OYLER JOHN | Chief Executive Officer | 03/05/2019 | 729,432 |
| OYLER JOHN | Chief Executive Officer | 03/04/2019 | 697,425 |
| Wang Xiaodong | Director | 03/01/2019 | 584,125 |
| Wang Xiaodong | Director | 03/01/2019 | 150,000 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/18/2018 | 295,103 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/17/2018 | 286,897 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/18/2018 | 1,356,312 |
| Peterson Amy C. | CMO, Immuno-oncology | 12/17/2018 | 1,317,225 |
| OYLER JOHN | Chief Executive Officer | 12/10/2018 | 561,863 |
| Wang Xiaodong | Director | 12/03/2018 | 762,060 |
| OYLER JOHN | Chief Executive Officer | 11/28/2018 | 1,304,863 |
| OYLER JOHN | Chief Executive Officer | 11/27/2018 | 1,626,741 |
| OYLER JOHN | Chief Executive Officer | 11/26/2018 | 1,262,428 |
| Huang Jane | CMO, Hematology | 11/26/2018 | 88,470 |
| Huang Jane | CMO, Hematology | 11/26/2018 | 418,749 |
| Wang Xiaodong | Director | 11/19/2018 | 621,489 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/12/2018 | 351,150 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/09/2018 | 384,760 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/08/2018 | 428,090 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/12/2018 | 1,360,348 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/09/2018 | 1,593,163 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/08/2018 | 1,854,578 |
| Huang Jane | CMO, Hematology | 09/04/2018 | 508,246 |
| Glazer Donald W. | Director | 08/30/2018 | 179,000 |
| Glazer Donald W. | Director | 08/29/2018 | 179,000 |
| Peterson Amy C. | CMO, Immuno-oncology | 08/23/2018 | 975,665 |
| Wang Xiaodong | Director | 08/13/2018 | 547,591 |
| BAKER BROS. ADVISORS LP | Director | 08/02/2018 | 627,922,800 |
| OYLER JOHN | Chief Executive Officer | 07/16/2018 | 418,498 |
| Liang Howard | CFO & Chief Strategy Officer | 03/19/2018 | 156,832 |
| Liang Howard | CFO & Chief Strategy Officer | 03/16/2018 | 70,668 |
| Liang Howard | CFO & Chief Strategy Officer | 03/19/2018 | 4,702,982 |
| Liang Howard | CFO & Chief Strategy Officer | 03/16/2018 | 1,707,669 |
| OYLER JOHN | Chief Executive Officer | 02/28/2018 | 5,036,940 |
| OYLER JOHN | Chief Executive Officer | 03/02/2018 | 3,756,785 |
| OYLER JOHN | Chief Executive Officer | 03/01/2018 | 5,623,203 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 02/28/2018 | 266,500 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 02/28/2018 | 1,468,761 |
| BAKER BROS. ADVISORS LP | Director | 01/18/2018 | 199,999,998 |
| OYLER JOHN | Chief Executive Officer | 12/26/2017 | 1,942,515 |
| Huang Jane | CMO, Hematology | 12/21/2017 | 29,510 |
| Huang Jane | CMO, Hematology | 12/21/2017 | 98,000 |
| Huang Jane | CMO, Hematology | 12/13/2017 | 44,265 |
| Huang Jane | CMO, Hematology | 12/13/2017 | 141,381 |
| OYLER JOHN | Chief Executive Officer | 12/08/2017 | 5,047,758 |
| OYLER JOHN | Chief Executive Officer | 12/07/2017 | 5,579,304 |
| OYLER JOHN | Chief Executive Officer | 12/06/2017 | 2,902,224 |
| Huang Jane | CMO, Hematology | 12/04/2017 | 94,600 |
| OYLER JOHN | Chief Executive Officer | 11/28/2017 | 2,820,864 |
| OYLER JOHN | Chief Executive Officer | 11/27/2017 | 1,438,582 |
| OYLER JOHN | Chief Executive Officer | 11/29/2017 | 3,013,458 |
| Huang Jane | CMO, Hematology | 11/20/2017 | 87,000 |
| Huang Jane | CMO, Hematology | 11/16/2017 | 51,000 |
| OYLER JOHN | Chief Executive Officer | 11/13/2017 | 2,080,916 |
| OYLER JOHN | Chief Executive Officer | 11/15/2017 | 5,300,508 |
| OYLER JOHN | Chief Executive Officer | 11/14/2017 | 4,770,950 |
| Peterson Amy C. | CMO, Immuno-oncology | 11/13/2017 | 298,747 |
| Peterson Amy C. | CMO, Immuno-oncology | 08/22/2017 | 151,830 |
| BAKER BROS. ADVISORS LP | Director | 08/11/2017 | 12,499,976 |
| Wang Xiaodong | Director | 07/12/2017 | 1,448,704 |
| Glazer Donald W. | Director | 07/10/2017 | 779,900 |
| OYLER JOHN | Chief Executive Officer | 07/06/2017 | 14,221,125 |
| Wang Xiaodong | Director | 06/28/2017 | 1,573,345 |
| OYLER JOHN | Chief Executive Officer | 06/23/2017 | 1,766,353 |
| OYLER JOHN | Chief Executive Officer | 06/22/2017 | 2,583,269 |
| Wang Xiaodong | Director | 06/02/2017 | 221,560 |
| Wang Xiaodong | Director | 05/04/2017 | 184,171 |
| Wang Xiaodong | Director | 05/03/2017 | 405,871 |
| OYLER JOHN | Chief Executive Officer | 05/01/2017 | 88,243 |
| OYLER JOHN | Chief Executive Officer | 04/27/2017 | 1,374,565 |
| Wang Xiaodong | Director | 04/05/2017 | 429,085 |
| Wang Xiaodong | Director | 03/24/2017 | 687,634 |
| Wang Xiaodong | Director | 03/23/2017 | 408,462 |
| Wang Xiaodong | Director | 03/22/2017 | 312,517 |
| OYLER JOHN | Chief Executive Officer | 03/20/2017 | 529,611 |
| OYLER JOHN | Chief Executive Officer | 03/17/2017 | 108,737 |
| OYLER JOHN | Chief Executive Officer | 03/16/2017 | 621,725 |
| Wang Xiaodong | Director | 03/10/2017 | 291,702 |
| Wang Xiaodong | Director | 03/09/2017 | 742,843 |
| Wang Xiaodong | Director | 03/08/2017 | 437,211 |
| OYLER JOHN | Chief Executive Officer | 03/03/2017 | 1,636,968 |
| OYLER JOHN | Chief Executive Officer | 03/02/2017 | 2,025,104 |
| OYLER JOHN | Chief Executive Officer | 03/06/2017 | 797,258 |
| Wang Xiaodong | Director | 02/27/2017 | 169,328 |
| Wang Xiaodong | Director | 02/24/2017 | 1,083,114 |
| Wang Xiaodong | Director | 02/23/2017 | 212,351 |
| OYLER JOHN | Chief Executive Officer | 02/17/2017 | 292,981 |
| OYLER JOHN | Chief Executive Officer | 02/16/2017 | 1,926,867 |
| OYLER JOHN | Chief Executive Officer | 02/21/2017 | 414,162 |
| Wang Xiaodong | Director | 11/23/2016 | 3,000,000 |
| Malley Thomas | Director | 11/23/2016 | 960,000 |
| BAKER BROS. ADVISORS LP | Director | 11/18/2016 | 56,335,840 |
| Glazer Donald W. | Director | 09/28/2016 | 1,271,175 |
| Glazer Donald W. | Director | 09/26/2016 | 611,300 |
| Glazer Donald W. | Director | 09/27/2016 | 784,691 |
| Glazer Donald W. | Director | 09/23/2016 | 351,793 |
| Glazer Donald W. | Director | 09/22/2016 | 778,561 |
| Glazer Donald W. | Director | 09/21/2016 | 508,958 |
| Glazer Donald W. | Director | 09/20/2016 | 255,615 |
| Glazer Donald W. | Director | 09/19/2016 | 1,348,487 |
| Liang Howard | CFO & Chief Strategy Officer | 02/08/2016 | 120,250 |
| Yuan RuiRong | Chief Medical Officer | 02/08/2016 | 240,500 |
| BAKER BROS. ADVISORS LP | Director | 02/08/2016 | 45,904,320 |
| BAKER BROS. ADVISORS LP | Director | 02/08/2016 | 1,750,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN BEIGENE LTD
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 10,776,565 | 11.21% | -7.65% | Other |
| HHLR ADVISORS, LTD. | 5,176,906 | 20.79% | No change | Other |
| BLACKROCK INC. | 805,694 | 0.00417% | -7.26% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 35,815 | 0.00077% | 0.57% | Other |
| BRIDGEWATER ASSOCIATES, LP | 12,118 | 0.01% | Exited | Other |
| RENAISSANCE TECHNOLOGIES LLC | 9,300 | 0.00239% | Exited | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,305 | 0.00744% | Exited | Growth |
| FISHER ASSET MANAGEMENT, LLC | 2,126 | 0.00021% | Exited | Other |
| TUDOR INVESTMENT CORP ET AL | 1,600 | 0.00289% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR BEIGENE LTD
STOCK BUYBACKS FOR BEIGENE LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
2.21%
1Q
03/31/2023
2.67%
2Q
12/31/2022
3.06%
3Q
09/30/2022
3.35%
4Q
06/30/2022
4.03%
5Q
03/31/2022
4.38%
6Q
12/31/2021
12.52%
7Q
09/30/2021
15.29%
8Q
06/30/2021
16.44%
9Q
03/31/2021
10.56%
10Q
12/31/2020
17.65%
11Q
09/30/2020
21.01%
12Q
06/30/2020
37.63%
13Q
03/31/2020
38.29%
14Q
12/31/2019
76.22%
15Q
09/30/2019
77.91%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BEIGENE LTD
LOADING...